Truvian in the news.

True blood? In the shadow of Theranos, Truvian revives dream of low-cost blood tests

San Diego Union Tribune- January 27, 2020

San Diego life sciences executive Jeff Hawkins is trying to bring credibility back to field rocked by scandal... Read more

...

ABC 10 News San Diego – KGTV Feature

ABC 10 News San Diego- December 30, 2019

Truvian featured by ABC 10 News San Diego - KGTV, as we open our new building. "A tiny machine promising big results with just a few drops of blood"... Read more

...

Company developing 5-drop, 20-minute blood test

ABC 6 News Philadelphia- December 23, 2019

A San Diego company is developing a device that could change the routine blood test. Truvian's system would deliver results on 40 tests in 20 minutes - with just 5 drops of blood, and for about 50 dollars... Read more

...

Blood testing nears a turning point as the evidence becomes undeniable

FierceBiotech- December 20, 2019

Blood has always held the keys to our bodies’ health: it helps carry nutrients in and waste out, and interrogating it can provide solace when we are well and answers when we are sick... Read more

...

Truvian Sciences Moves Closer to Commercialization of Benchtop Blood Testing System

BioSpace- December 10, 2019

Despite all her failings and unethical behavior as head of Theranos, Elizabeth Holmes got one thing right – and that was her early realization that consumers would want access to a personalized diagnostics tool... Read more

...

Truvian Seeks to Decentralize Blood Testing

San Diego Business Journal- December 3, 2019

Truvian Sciences wants to run a battery of tests on only drops of blood. Its mobile lab is designed to return answers in 20 minutes. Sound a little familiar?... Read more

...

Health tech funding snapshot—Sony joins $42M round in endoscopy AI company; Wellframe raises $20M

FierceBiotech- November 27, 2019

San Diego-based healthcare company Truvian Sciences wants to disrupt the $80 billion blood-testing market. The company closed a $27.1 million series B financing round, led by GreatPoint Ventures... Read more

...

Health and Life Science Deals

Fortune- November 26, 2019

Truvian Sciences, a San Diego, Calif.-based developer of automated diagnostic equipment which provides health test services, raised $27.1 million in Series B funding... Read more

...

Funding Goes to Cancer Drug Developers, Company Billed as the Anti-Theranos

San Diego Business Journal- November 24, 2019

Seeking and destroying lung cancer. Succeeding where Theranos failed. Treating resistant breast cancers. These are the aims of three San Diego biotechs that recently received funding... Read more

...

Truvian Sciences Raises $27m As It Tries To Succeed Where Theranos Failed

Mass Device- November 22, 2019

The idea of a benchtop blood testing system only needing a few drops of blood has gotten a bad rap since Theranos’ collapse. But that hasn’t stopped Truvian Sciences from trying to develop its own system... Read more

...

Truvian Sciences Looks to Disrupt Dx Market With Three-Modality Platform

360Dx- November 21, 2019

Theranos sounded too good to be true – and it was. Truvian Sciences has heard the comparisons to Elizabeth Holmes' company and wants you to know it's different... Read more

...

Theranos-like Blood-testing Startup Raises $27m

Becker's Hospital Review- November 21, 2019

Truvian Sciences, a startup developing an automated benchtop system that can rapidly perform multiple tests on just a few drops of blood, announced Nov. 20 the close of its Series B financing... Read more

...

Blood Test Startup Truvian Sciences Closes $27M Series B Financing Round

360Dx- November 20, 2019

Truvian Sciences announced Wednesday that it has closed a $27.1 million Series B financing round to support the company's development of an automated benchtop system to provide lab accurate results in 20 minutes... Read more

...

Truvian Nets $27m To Build Its Comprehensive Benchtop Blood Testing Machine

FierceBiotech- November 20, 2019

Truvian Sciences raised $27.1 million to fuel the development of its benchtop blood tester, bringing the San Diego-based company’s total funding to date up to $46.3 million... Read more

...

Truvian Sciences Raises $27.1m For A Testing System Needing Only “A Small Sample Of Blood”

MedCityNews- November 20, 2019

Truvian Sciences is developing an automated benchtop broad panel testing system on a “small sample of blood” to support which the company just raised $27.1 million... Read more

...

With Echoes Of Theranos, Truvian Sciences Revives The Dream Of Low-cost, Accessible Blood Tests

TechCrunch- November 20, 2019

A little over a year after the dissolution of the once high-flying blood testing startup Theranos, another startup has raised more than $27 million to breathe new life into the vision of bringing low-cost blood tests to point-of-care medical facilities... Read more

...

Blood-Testing Startup Truvian Raises Fresh Capital

The Wall Street Journal- November 20, 2019

New funding will be used to finance validation studies and regulatory submission... Read more

...

Great Point Ventures Leads Series B Round For Truvian Sciences

peHUB Network- November 20, 2019

Truvian Sciences, a provider of routine health testing services, has secured $27.1 million in Series B financing... Read more

...

The latest from Truvian.

Truvian Sciences Appoints Shane Bowen, Ph.D. as Senior Vice President of Engineering

February 3, 2020

Former Senior Director at Illumina, Inc. was Instrumental in Developing the World-Class Sequencing System that Enabled the $1000 Genome SAN DIEGO, Feb. 03, 2020 — Truvian Sciences (“Truvian”), a healthcare company at the intersection of diagnostics and consumer technology, today announced... Read more

...

Truvian Sciences Debuts New Headquarters in San Diego

December 19, 2019

Company Moves to New World-Class Laboratory and Office Space on Heels of $27.1 Million Series B Financing SAN DIEGO, Dec. 19, 2019 — Truvian Sciences (“Truvian”) will celebrate today the official debut of the company’s new 36,000 square-foot headquarters in... Read more

...

Truvian Sciences Accelerates Plans With $27.1 Million Series B Financing to Develop an Automated Benchtop Blood Testing System for Rapid Assessment of a Full Suite of Health Tests

November 20, 2019

Company Aims to Make Routine Health Testing Convenient, Affordable and Actionable Led by Former Illumina Executive Jeff Hawkins as Chief Executive Officer Company Expands Leadership Team with the Addition of Katherine Atkinson as Chief Commercial Officer and Paul Meister to... Read more

...